News
Rhythm Pharmaceuticals' potential first-in-class HO drug, strong pipeline, and limited competition offer blockbuster potential. Click to read why RYTM is a Buy.
The number of performing rights organizations has proliferated in recent years, leaving some venues struggling to pay fees ...
This year, BMI estimates global copper mine output to rise 2.5% as production in Chile recovers and the giant Oyu Tolgoi mine ...
5h
HealthDay on MSNStratifying BMI by Waist Circumference Improves Mortality Risk Prediction in Postmenopausal WomenStratifying body mass index (BMI) categories by waist circumference (WC) thresholds improves mortality risk prediction in ...
CHAR Tech’s contribution to the Thorold Project includes construction in progress and ongoing procurement activities, a use of technology licence, as well as expected and ongoing CHAR Tech engineering ...
6h
Zacks Investment Research on MSNRYTM Stock Rises on Upbeat Acquired Hypothalamic Obesity Study DataShares of Rhythm Pharmaceuticals RYTM were up 36.6% yesterday after it reported positive top-line data from a phase II study ...
Know your heart disease risk. It’s smart to have your heart risk assessed and “know your numbers” (BMI, blood pressure, blood sugar, cholesterol). If you’re obese, be watchful for signs of heart ...
HealthDay News — The European Association for the Study of Obesity (EASO) framework may offer a more sensitive measure of obesity than traditional body mass index (BMI), according to a study published ...
Rhythm Pharmaceuticals is advancing its oral obesity drug bivamelagon to Phase III studies after it significantly reduced ...
Health and wellness experts unanimously agreed that Body Mass Index (BMI) should not be taken as an accurate indicator of overall health. They said it must be considered within the context of other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results